Evidence map›Paper›PMID 34590055›Full record

ArticleJTO clinical and research reports2021

First-in-Human Segmental Esophageal Reconstruction Using a Bioengineered Mesenchymal Stromal Cell-Seeded Implant.

Johnathon M Aho, Saverio La Francesca, Scott D Olson, Fabio Triolo, Jeff Bouchard, Laura Mondano, Sumati Sundaram, Christina Roffidal, Charles S Cox, Louis M Wong Kee Song and 3 more

Open access · goldAbstract read
In one paragraph

Article in JTO clinical and research reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 15 citations in OpenAlex.

  1. Esophagus engineering tackles function.Nature biotechnology · 2026
    Article
  2. Article
  3. Review
  4. Advances in Functional Scaffolds for Bone and Joint Surgery.Journal of functional biomaterials · 2025
    Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Development and Prospect of Esophageal Tissue Engineering.Frontiers in bioengineering and biotechnology · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 1 country.

Johnathon M AhoDivision of General Thoracic Surgery, Department of Surgery, Mayo Clinic, Rochester, Minnesota.
Saverio La FrancescaBiostage, Holliston, Massachusetts.
Scott D OlsonDepartment of Pediatric Surgery, McGovern Medical School, UTHealth, The University of Texas Health Science Center, Houston, Texas.
Fabio TrioloDepartment of Pediatric Surgery, McGovern Medical School, UTHealth, The University of Texas Health Science Center, Houston, Texas.
Jeff BouchardBiostage, Holliston, Massachusetts.
Laura MondanoBiostage, Holliston, Massachusetts.
Sumati SundaramBiostage, Holliston, Massachusetts.
Christina RoffidalBiostage, Holliston, Massachusetts.
Charles S CoxDepartment of Pediatric Surgery, McGovern Medical School, UTHealth, The University of Texas Health Science Center, Houston, Texas.
Louis M Wong Kee SongGastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota.
Sameh M SaidCardiovascular Surgery, Mayo Clinic, Rochester, Minnesota.
William FodorBiostage, Holliston, Massachusetts.
Dennis A WigleDivision of General Thoracic Surgery, Department of Surgery, Mayo Clinic, Rochester, Minnesota.
Mayo Clinic · USThe University of Texas Health Science Center at Houston · USWinnMed · US

Funding

Interdisciplinary Training in Lung Physiology and Biomedical EngineeringT32HL105355 · NHLBI · MAYO CLINIC ROCHESTER · PI PRAKASH, Y. S., SIECK, GARY C. · 2012 to 2021
$3.9M
NHLBI NIH HHS T32 HL105355
6 · The paper itself

Abstract

introductionResection and reconstruction of the esophagus remains fraught with morbidity and mortality. Recently, data from a porcine reconstruction model revealed that segmental esophageal reconstruction using an autologous mesenchymal stromal cell-seeded polyurethane graft (Cellspan esophageal implant [CEI]) can facilitate esophageal regrowth and regeneration. To this end, a patient requiring a full circumferential esophageal segmental reconstruction after a complex multiorgan tumor resection was approved for an investigational treatment under the Food and Drug Administration Expanded Access Use (Investigational New Drug 17402).

methodsAutologous adipose-derived mesenchymal stromal cells (Ad-MSCs) were isolated from the Emergency Investigational New Drug patient approximately 4 weeks before surgery from an adipose tissue biopsy specimen. The Ad-MSCs were grown and expanded under current Good Manufacturing Practice manufacturing conditions. The cells were then seeded onto a polyurethane fiber mesh scaffold (Cellspan scaffold) and cultured in a custom bioreactor to manufacture the final CEI graft. The cell-seeded scaffold was then shipped to the surgical site for surgical implantation. After removal of a tumor mass and a full circumferential 4 cm segment of the esophagus that was invaded by the tumor, the CEI was implanted by suturing the tubular CEI graft to both ends of the remaining native esophagus using end-to-end anastomosis.

resultsIn this case report, we found that a clinical-grade, tissue-engineered esophageal graft can be used for segmental esophageal reconstruction in a human patient. This report reveals that the graft supports regeneration of the esophageal conduit. Histologic analysis of the tissue postmortem, 7.5 months after the implantation procedure, revealed complete luminal epithelialization and partial esophageal tissue regeneration.

conclusionsAutologous Ad-MSC seeded onto a tubular CEI tissue-engineered graft stimulates tissue regeneration following implantation after a full circumferential esophageal resection.

Indexed as

Artificial organEsophageal reconstructionEsophageal replacementTissue engineered graft

Identifiers

PMID34590055
PMCPMC8474397
OpenAlexW3189304899

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.